137 related articles for article (PubMed ID: 36597712)
21. Novel Germline c.105_107dupGCT
Stasiak M; Dedecjus M; Zawadzka-Starczewska K; Adamska E; Tomaszewska M; Lewiński A
Genes (Basel); 2020 Aug; 11(9):. PubMed ID: 32847108
[TBL] [Abstract][Full Text] [Related]
22. The Importance of Periodical Screening for Primary Hyperparathyroidism in a Pituitary Tumor Cohort in Searching Patients With MEN1 and Its Genetic Profile.
Damianse SSP; Nascimento GC; Rocha VCC; Nascimento AGPAC; Gaido NC; Azulay RSS; Dos Santos WC; Rodrigues VP; Quidute ARP; Magalhães M; Dos S Faria M
Endocr Pract; 2022 May; 28(5):509-514. PubMed ID: 35247589
[TBL] [Abstract][Full Text] [Related]
23. No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia.
Raitila A; Georgitsi M; Karhu A; Tuppurainen K; Mäkinen MJ; Birkenkamp-Demtröder K; Salmenkivi K; Orntoft TF; Arola J; Launonen V; Vahteristo P; Aaltonen LA
Endocr Relat Cancer; 2007 Sep; 14(3):901-6. PubMed ID: 17914118
[TBL] [Abstract][Full Text] [Related]
24. Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutation.
Williams F; Hunter S; Bradley L; Chahal HS; Storr HL; Akker SA; Kumar AV; Orme SM; Evanson J; Abid N; Morrison PJ; Korbonits M; Atkinson AB
J Clin Endocrinol Metab; 2014 Apr; 99(4):1122-31. PubMed ID: 24423289
[TBL] [Abstract][Full Text] [Related]
25. Familial isolated pituitary adenomas: an emerging clinical entity.
Martucci F; Trivellin G; Korbonits M
J Endocrinol Invest; 2012 Dec; 35(11):1003-14. PubMed ID: 23310926
[TBL] [Abstract][Full Text] [Related]
26. AIP mutations and gigantism.
Rostomyan L; Potorac I; Beckers P; Daly AF; Beckers A
Ann Endocrinol (Paris); 2017 Jun; 78(2):123-130. PubMed ID: 28483363
[TBL] [Abstract][Full Text] [Related]
27. Pituitary gigantism: a case series from Hospital de San José (Bogotá, Colombia).
García WR; Cortes HT; Romero AF
Arch Endocrinol Metab; 2019 Jul; 63(4):385-393. PubMed ID: 31365626
[TBL] [Abstract][Full Text] [Related]
28. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia.
Georgitsi M; Raitila A; Karhu A; van der Luijt RB; Aalfs CM; Sane T; Vierimaa O; Mäkinen MJ; Tuppurainen K; Paschke R; Gimm O; Koch CA; Gündogdu S; Lucassen A; Tischkowitz M; Izatt L; Aylwin S; Bano G; Hodgson S; De Menis E; Launonen V; Vahteristo P; Aaltonen LA
J Clin Endocrinol Metab; 2007 Aug; 92(8):3321-5. PubMed ID: 17519308
[TBL] [Abstract][Full Text] [Related]
29. The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations.
Ozawa A; Agarwal SK; Mateo CM; Burns AL; Rice TS; Kennedy PA; Quigley CM; Simonds WF; Weinstein LS; Chandrasekharappa SC; Collins FS; Spiegel AM; Marx SJ
J Clin Endocrinol Metab; 2007 May; 92(5):1948-51. PubMed ID: 17299066
[TBL] [Abstract][Full Text] [Related]
30. Novel mutations in MEN1, CDKN1B and AIP genes in patients with multiple endocrine neoplasia type 1 syndrome in Spain.
Belar O; De La Hoz C; Pérez-Nanclares G; Castaño L; Gaztambide S;
Clin Endocrinol (Oxf); 2012 May; 76(5):719-24. PubMed ID: 22026581
[TBL] [Abstract][Full Text] [Related]
31. [Gigantism caused by a double-secreting (GH-PRL) acidophile adenoma in a 6-year-old girl].
Rusconi R; Ballabio G; Piceni Sereni L
Minerva Pediatr; 1985 Oct; 37(20):815-9. PubMed ID: 3005820
[No Abstract] [Full Text] [Related]
32. Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients.
Rostomyan L; Daly AF; Petrossians P; Nachev E; Lila AR; Lecoq AL; Lecumberri B; Trivellin G; Salvatori R; Moraitis AG; Holdaway I; Kranenburg-van Klaveren DJ; Chiara Zatelli M; Palacios N; Nozieres C; Zacharin M; Ebeling T; Ojaniemi M; Rozhinskaya L; Verrua E; Jaffrain-Rea ML; Filipponi S; Gusakova D; Pronin V; Bertherat J; Belaya Z; Ilovayskaya I; Sahnoun-Fathallah M; Sievers C; Stalla GK; Castermans E; Caberg JH; Sorkina E; Auriemma RS; Mittal S; Kareva M; Lysy PA; Emy P; De Menis E; Choong CS; Mantovani G; Bours V; De Herder W; Brue T; Barlier A; Neggers SJ; Zacharieva S; Chanson P; Shah NS; Stratakis CA; Naves LA; Beckers A
Endocr Relat Cancer; 2015 Oct; 22(5):745-57. PubMed ID: 26187128
[TBL] [Abstract][Full Text] [Related]
33. A novel germline mutation of multiple endocrine neoplasia type 1 (MEN1) gene in a Japanese MEN1 patient and her daughter.
Ohye H; Sato M; Matsubara S; Miyauchi A; Kishi-Imai K; Murao K; Takahara J
Endocr J; 1999 Apr; 46(2):325-9. PubMed ID: 10460018
[TBL] [Abstract][Full Text] [Related]
34. Screening of
Tuncer FN; Çiftçi Doğanşen S; Serbest E; Tanrıkulu S; Ekici Y; Bilgiç B; Yarman S
Genet Test Mol Biomarkers; 2018 Dec; 22(12):702-708. PubMed ID: 30461320
[No Abstract] [Full Text] [Related]
35. The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas.
Iwata T; Yamada S; Mizusawa N; Golam HM; Sano T; Yoshimoto K
Clin Endocrinol (Oxf); 2007 Apr; 66(4):499-502. PubMed ID: 17371465
[TBL] [Abstract][Full Text] [Related]
36. Gigantism in sibling unrelated to multiple endocrine neoplasia: case report.
Matsuno A; Teramoto A; Yamada S; Kitanaka S; Tanaka T; Sanno N; Osamura RY; Kirino T
Neurosurgery; 1994 Nov; 35(5):952-5; discussion 955-6. PubMed ID: 7838348
[TBL] [Abstract][Full Text] [Related]
37. Somatic MEN1 gene mutation does not contribute significantly to sporadic pituitary tumorigenesis.
Poncin J; Stevenaert A; Beckers A
Eur J Endocrinol; 1999 Jun; 140(6):573-6. PubMed ID: 10366412
[TBL] [Abstract][Full Text] [Related]
38. Gigantism associated with a pituitary tumour secreting growth hormone and prolactin and cured by transsphenoidal hypophysectomy.
Favre L; Rogers LM; Cobb CA; Rabin D
Acta Endocrinol (Copenh); 1979 Jun; 91(2):193-200. PubMed ID: 223354
[TBL] [Abstract][Full Text] [Related]
39. Eight-year follow-up of a child with a GH/prolactin-secreting adenoma: efficacy of pegvisomant therapy.
Bergamaschi S; Ronchi CL; Giavoli C; Ferrante E; Verrua E; Ferrari DI; Lania A; Rusconi R; Spada A; Beck-Peccoz P
Horm Res Paediatr; 2010; 73(1):74-9. PubMed ID: 20190543
[TBL] [Abstract][Full Text] [Related]
40. Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: an update.
Karhu A; Aaltonen LA
Hum Mol Genet; 2007 Apr; 16 Spec No 1():R73-9. PubMed ID: 17613551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
